
    
      The objective of this study is to evaluate safety, compatibility and imaging quality of the
      ExAblate MRgFUS system for prostate cancer, under simulated use conditions. No acoustic
      energy will be delivered and no focused ultrasound therapy will be performed. This is an
      imaging only study.
    
  